APA (7th ed.) Citation

Fischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., . . . Allan, J. D. (1990). The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Annals of Internal Medicine, 112(10), 727. https://doi.org/10.7326/0003-4819-112-10-727

Chicago Style (17th ed.) Citation

Fischl, M A., et al. "The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection. A Double-blind, Placebo-controlled Trial. The AIDS Clinical Trials Group." Annals of Internal Medicine 112, no. 10 (1990): 727. https://doi.org/10.7326/0003-4819-112-10-727.

MLA (9th ed.) Citation

Fischl, M A., et al. "The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection. A Double-blind, Placebo-controlled Trial. The AIDS Clinical Trials Group." Annals of Internal Medicine, vol. 112, no. 10, 1990, p. 727, https://doi.org/10.7326/0003-4819-112-10-727.